Pres, CEO
Cameron John Reynolds is an experienced entrepreneurial executive specializing in biotechnology companies, serving as President, Chief Executive Officer, and Director of VolitionRx Ltd (VNRX) since 2011.[[1]](https://www.gurufocus.com/insider/28283/cameron-john-reynolds)[[2]](https://ir.volition.com/company-information/executive-team)[[3]](https://ir.volition.com/corporate-governance/board-of-directors)[[6]](https://www.marketscreener.com/insider/CAMERON-REYNOLDS-A09UHK/) He holds significant ownership in the company, with approximately 3.37 million shares valued at over $3 million as of June 2025, and has actively purchased shares, including 110,000 shares on October 14, 2025, for $56,100 and 12,500 shares on June 12, 2025.[[1]](https://www.gurufocus.com/insider/28283/cameron-john-reynolds)[[4]](https://www.quiverquant.com/news/Insider+Purchase:+President+and+CEO+of+$VNRX+Buys+110,000+Shares) Reynolds has a history of leadership roles across multiple firms, including CEO of Kal Energy Inc (2007), Director and CFO of Searchlight Resources Inc (2004), and positions at Hypergenomics Pte Ltd and Singapore Volition.[[1]](https://www.gurufocus.com/insider/28283/cameron-john-reynolds)[[5]](http://boards.industrial-linguistics.com/directors/cameron+reynolds.html)[[6]](https://www.marketscreener.com/insider/CAMERON-REYNOLDS-A09UHK/)
Educated at the University of Western Australia, where he earned a Bachelor of Commerce and an MBA, Reynolds brings expertise in management, structuring, and strategic planning of start-up companies, having held roles such as CEO, CFO, and Non-Executive Director in public and private enterprises.[[2]](https://ir.volition.com/company-information/executive-team)[[3]](https://ir.volition.com/corporate-governance/board-of-directors) His compensation at VolitionRx Ltd in 2023 totaled $772,933, including salary, bonus, and stock awards.[[1]](https://www.gurufocus.com/insider/28283/cameron-john-reynolds)
View full insider profile →
